While HGF-activating enzymes are upregulated in lung cancer (Supplementary Figure 2), the levels of HAI-1/2 are commonly reduced in cancer tissue, resulting in increased activation of HGF. The gene discussed is SPINT1; the disease is lung carcinoma.